Holly A. Porter, Ph.D.
Affiliations: | 2012 | Molecular Medicine | University of Maryland School of Medicine, Baltimore, MD, United States |
Area:
Molecular Biology, Cell Biology, OncologyGoogle:
"Holly Porter"Parents
Sign in to add mentor| Achsah D. Keegan | grad student | 2012 | University of Maryland Medical School | |
| (Role of Insulin Receptor Substrate Proteins in Protection from Chemotherapy-induced Cell Death.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Porter HA, Perry A, Kingsley C, et al. (2013) IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors. Cancer Letters. 338: 239-48 |
| Porter HA, Carey GB, Keegan AD. (2012) Insulin receptor substrate 1 expression enhances the sensitivity of 32D cells to chemotherapy-induced cell death. Experimental Cell Research. 318: 1745-58 |
| Porter HA, Keegan AD. (2010) Abstract 4014: Differential expression and activation of IRS1 and IRS2 in breast cancer cell lines Cancer Research. 70: 4014-4014 |
| Porter HA, Keegan AD. (2008) 16 IRS1 expression enhances the sensitivity of 32D cells to chemotherapy-induced cell death Cytokine. 43: 240 |